Prostate Cancer

American Cancer Society. (1996). Cancer facts and figures – 1996. Atlanta: Author.

Baquet C.R. Horm J.W. Gibbs T. , & Greenwald P. (1991). Socioeconomic factors and cancer incidence among blacks and whites. Journal of the National Cancer Institute, 83, 551–557.

Barry M.J. Girman C.J. O'Leary M.P. Walker-Corkery E.S. Binkowitz B.S. Cockett A.T. , & Guess H.A. (1995). Using repeated measures of symptom score, uroflowmetry and prostatic specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group. Journal of Urology, 153, 99–103.

Bean M. Tatani R. Lui P. Fukazawa K. Ashley F.W. , & Fujita S. (1973). Prostate carcinoma at autopsy in Hiroshima and Nagasaki Japanese. Cancer, 32, 498–506.

Benson M.C. Whang I.S. Olsson C.A. McMahon D.J. , & Cooner W.H. (1992). The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. Journal of Urology, 147, 817–821.

Brawer M. K. Beatie J. Wener M.H. Vessella R.L. Preston S.D. , & Lange P.H. (1993). Screening for prostatic carcinoma with prostate specific antigen: Results of the second year. Journal of Urology, 150, 106–109.

Brawn P.N. Speights V.O. Kuhl D. Riggs M. Lind M.L. Coffield K.S. , & Weaver B. (1996). Prostate specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer, 68, 1592–1599.

Brett A.S. (1995). The mammography and prostate specific antigen controversies: Implications for patient-Physician encounters and public policy. Journal of General Internal Medicine, 10, 266–270.

Carter H.B. , & Pearson J.D. (1993). PSA velocity for the diagnosis of early prostate cancer. A new concept. Urology Clinics of North America, 20, 665–670.

Carter H.B. Pearson J.D. Metter E.J. Brant L.J. Chan D.W. Andres R. Fozard J.C. , & Walsh P.C. (1992). Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA, 267, 2215–2220.

Catalona W.J. Richie J.P. Ahmann F.R. Hudson M.A. Scardino P.T. Flanigan R.C. deKernion J.B. Ratliff T.L. Kavossi L.R. , & Dalkin B.L. (1994). Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. Journal of Urology, 151, 1283–1290.

Catalona W.J. Smith D.S. Wolfert R.L. Wang T.J. Rittenhouse G. II Ratliff T.L. , & Nadler R.B. (1995). Evaluation of percentage of free serum prostate specific antigen to improve specificity of cancer screening. JAMA, 274, 1214–1220.

Chodak G.W. Thisted R.A. Gerber G.S. Johansson J.E. Adolfsson J. Jones G.W. Chisholm G.D. Moskovit Z.B. Livne P.M. , & Warner J. (1994). Results of conservative management of clinically localized prostate cancer. New England Journal of Medicine, 330, 242–248.

Coley C.M. Barry M.J. Flemming C. , & Mulley A.G. (1997). Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. Annals of Internal Medicine, 126(5), 394–406.

Dodds P.R. Caride V.J. , & Lytton B. (1981). The role of vertebral veins in the dissemination of prostate carcinoma. Journal of Urology, 126, 753–755.

Dole E.J. , & Holdsworth M.T. (1997). Nilutamide: An antiandrogen for the treatment of prostate cancer. Annals of Pharmacotherapy, 31, 65–74.

Emmett J.L. Barber K.W. Jr. , & Jackman R.J. (1962). Transrectal biopsy to detect prostatic carcinoma: A review and report of cases. Journal of Urology, 87, 460–474.

Fleming C. Wasson J.H. Albertson P.C. Barry M.J. , & Wennberg J.E. (1993). A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate patient outcomes research team. JAMA, 269, 2650–2658.

Giovannucci E. Ascherio A. Rimm E.B. Colditz G.A. Stampfer M.J. , & Willet W.C. (1993a). A prospective study of vasectomy and prostate cancer in US men. JAMA, 269, 873–877.

Giovannucci E. Rimm E.B. Colditz G.A. Stampfer M.J. Ascherio A. Chute C.C. , & Willet W.C. (1993b). A prospective study of dietary fat and risk of prostate cancer. Journal of the National Cancer Institute, 85, 1571–1579.

Golimbu M. Morales P. Al-Askari S. , & Brown J. (1979). Extended pelvic lymphadenectomy for prostate cancer. Journal of Urology, 121, 617–619.

Hunter J. (1788). Treatise on venereal disease. London.

Johansson J.E. Adami H.O. Anderson S.O. Bergstrom R. Holmberg L. , & Krusemo U.B. (1992). High ten-year survival rate in patients with early, untreated prostate cancer. JAMA, 267, 2191–2196.

Johansson J.E. Anderson S. O. Krusemo U.B. Bergstrom R. , & Kraaz W. (1989). Natural history of localized prostate cancer. Lancet, 1, 799–803.

Keetch D.W. Catalona W.J. , & Smith D.S. (1994). Serial prostate biopsies in men with persistently elevated prostate specific antigen values. Journal of Urology, 151, 1571–1574.

Kipling M.D. , & Waterhouse J.A.H. (1976). Cadmium and prostate cancer. Lancet, 1, 730–731.

Kopelson G. Harisiadis L. Romas N.A. Veenema R.J. , & Tannenbaum M. (1978). Periurethral prostatic duct carcinoma: Clinical features and treatment results. Cancer, 42, 2894–2902.

Landes S.H. Murray T. , & Bolden S. (1998). Cancer statistics, 1998. Ca-A Cancer Journal for Clinicians, 48(1), 6–29.

Mettlin C. Lee F. Drago J. , & Murphy G.P. (1993). The American Cancer Society national prostate cancer detection project: Findings on the detection of early prostate cancer in 2,425 men. Cancer, 67, 2949–2958.

Moul J.W. Douglas T.H. McCarthy W.F. , & McLeod D.G. (1996). Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. Journal of Urology, 155, 1667–1673.

Oesterling J.E. Jacobsen S.J. , & Cooner W.H. (1995). The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old and older. Journal of Urology, 153, 1160–1163.

Ries L.A. Miller B.A. Hankey B.F. Kosary C.I. Harras A. , & Edwards B.K. (Eds.), (1994). SEER cancer statistics review, 1973–1991. Tables and graphs. National Cancer Institute. NTH Publication No. 94-2789, Bethesda, MD.

Rotkin I. (1977). Studies in epidemiology of prostate cancer: Expanding sample. The Cancer Treatment Report, 61, 173–179.

Shimizu T.S. Uchida T. Satoh F. Imai K. , & Yamanaka H. (1995). Prostate specific antigen in mass screening for carcinoma of the prostate. International Journal of Urology, 2, 257–260.

Smith D.S. (1995). Genitourinary tumors. In Tanagho E.A. (Ed.). Smith's general urology (pp. 410–427). Los Altos, CA: Lange.

Spitz M.R. Currier R.D. Fueger J.J. Babian R.J. , & Newell G.R. (1991). Familial patterns of prostate cancer: A case control analysis. Journal of Urology, 146, 1305–1307.

Steinberg G.D. Carter B.S. Beaty T.H. Childs B. , & Walsh P.C. (1990). Family history and the risk of prostate cancer. Prostate, 17, 337–347.

Terris M.K. McNeal J.E. , & Stamey T.A. (1992). Detection of clinically significant prostate cancer by transrectal ultrasound guided systematic biopsies. Journal of Urology, 148, 829–832.

Van der Gulden J.W.J. Kolk J.J. , & Verbeek A.L.M. (1995). Work environment and prostate cancer risk. Prostate, 27(5), 250–257.

Vashi A.R. , & Oesterling J.E. (1997). Percent free prostate specific antigen: Entering a new era in the detection of prostate cancer. Mayo Clinic Proceedings, 72, 337–344.

Villers A. McNeal J.E. Redwine E.A. Freiha F.S. , & Stamey T.A. (1989). The role of perineural space invasion in the local spread of prostatic adenocarcinoma. Journal of Urology, 142, 763–768.

Villers A. Terris M.K. McNeal J.E. , & Stamey T.A. (1990). Ultrasound anatomy of the prostate: The normal gland and anatomical variations. Journal of Urology, 143, 732–738.

Walsh P.C. (1975). Physiologic basis for hormonal therapy in carcinoma of the prostate. Urological Clinics of North America, 2, 125.

Walsh P.C. , & Mostwin J.L. (1984). Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve sparing technique. British Journal of Urology, 56, 694–697.

Weinerii J.L. , & Roberson C.N. (1997). Urologic surgery, 1565–1567. In: Sabiston's textbook of surgery: The biological basis of modern surgical practice, 12th ed. Philadelphia: W.B. Saunders.

Wynder E. Mabushi K. , & Whitmore W. Jr. (1971). Epidemiology of cancer of the prostate. Cancer, 18, 344–360.

Young H.H. , & Davis D.M. (1926). Young's practice of urology. Philadelphia: W.B. Saunders.